UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032724
Receipt number R000037277
Scientific Title Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure.
Date of disclosure of the study information 2018/05/25
Last modified on 2019/05/27 11:33:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure.

Acronym

Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure.

Scientific Title

Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure.

Scientific Title:Acronym

Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure.

Region

Japan


Condition

Condition

heart failure

Classification by specialty

Cardiology Radiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study sought to clarify the correlation of CVP and liver stiffness measured by MR elastography, and determine the relationship between liver stiffness and the prognosis of heart failure.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. the correlation of CVP and liver stiffness measured by MR elastography in heart failure patients
2. the relationship between liver stiffness measured by MR elastography and the prognosis of heart failure (all cause death, re-hospitalization for heart failure).

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. heart failure group
Heart failure patients admitted to Hokkaido University Hospital.
2. non heart failure group
A person who has no apparent history of heart failure at the time of participation in research at Hokkaido University Hospital.

* The definition of "heart failure" in this study shall be in accordance with the guidelines published by the European Society of Cardiology in 2016.

Key exclusion criteria

1. Patients who have organic liver disease such as chronic liver injury, liver cirrhosis, hepatocellular carcinoma
2. Patients who are inappropriate for MRI imaging
3. Patients who are judged to be inappropriate as the research subject by the research staff

Target sample size

330


Research contact person

Name of lead principal investigator

1st name Toshihisa
Middle name
Last name Anzai

Organization

Hokkaido University Hospital

Division name

Department of Cardiovascular Medicine

Zip code

0608648

Address

Kita15 Nishi7,Kita-ku,Sapporo,Hokkaido

TEL

011-706-6973

Email

anzai@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Toshiyuki
Middle name
Last name Nagai

Organization

Hokkaido University Hospital

Division name

Department of Cardiovascular Medicine

Zip code

0608648

Address

Kita15 Nishi7,Kita-ku,Sapporo,Hokkaido

TEL

011-706-6973

Homepage URL


Email

tnagai@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Hospital Clinical Research and Medical Inovation Center

Address

Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido, 060-8648 Japan

Tel

011-706-7061

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 03 Month 12 Day

Date of IRB

2018 Year 03 Month 12 Day

Anticipated trial start date

2018 Year 04 Month 26 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective observational study


Management information

Registered date

2018 Year 05 Month 25 Day

Last modified on

2019 Year 05 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037277


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name